Encyclopedia of Gerontology and Population Aging

Living Edition
| Editors: Danan Gu, Matthew E. Dupre

Longevity Activism

  • Ilia StamblerEmail author
  • Elena Milova
Living reference work entry
DOI: https://doi.org/10.1007/978-3-319-69892-2_395-1

Synonyms

Definition

Longevity activism refers to public activities and advocacy directed toward the promotion of healthy longevity of the population, via advancement of biomedical science, promoting education and public health and science policy toward that purpose.

Overview

There is now an emerging international social advocacy movement dedicated to promotion of biomedical research and development to alleviate aging-related morbidity, extend healthy period of life, and improve healthy longevity for the elderly population. It is commonly referred to by the activists as the “longevity movement” or “longevity research and advocacy movement,” as well as “healthy life extension movement.” It is a “hybrid” between the aged rights advocacy, patient advocacy, and science advocacy, as it emphasizes the need to implement preventive medicine to improve health care for the elderly around the world via enhanced medical scientific research with a special focus on the mechanisms...

This is a preview of subscription content, log in to check access.

References

  1. Anisimov VN, Sidorenko AV (2018) It is necessary to establish an international agency for research on aging. Aging (Albany NY) 10(5):863–867.  https://doi.org/10.18632/aging.101451CrossRefGoogle Scholar
  2. Bannister C, Holden SE, Jenkins-Jones S et al (2014) Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls. Diabetes Obes Metab 16:1165–1173.  https://doi.org/10.1111/dom.12354CrossRefGoogle Scholar
  3. de Grey AD, Ames BN, Andersen JK et al (2001) Time to talk SENS: critiquing the immutability of human aging. Ann N Y Acad Sci 959:452–462.  https://doi.org/10.1111/j.1749-6632.2002.tb02115.xCrossRefGoogle Scholar
  4. Donner Y, Fortney K, Calimport SR et al (2016) Great desire for extended life and health amongst the American public. Front Genet 6:353.  https://doi.org/10.3389/fgene.2015.00353CrossRefGoogle Scholar
  5. Dragojlovic N (2013) Canadians’ support for radical life extension resulting from advances in regenerative medicine. J Aging Stud 27(2):151–158.  https://doi.org/10.1016/j.jaging.2012.12.008CrossRefGoogle Scholar
  6. Fontana L, Kennedy BK, Longo VD et al (2014) Medical research: treat ageing. Nature 511(7510):405–407.  https://doi.org/10.1038/511405aCrossRefGoogle Scholar
  7. Goldman DP, Cutler DM, Rowe JW et al (2013) Substantial health and economic returns from delayed aging may warrant a new focus for medical research. Health Aff 32(10):1698–1705.  https://doi.org/10.1377/hlthaff.2013.0052CrossRefGoogle Scholar
  8. Hall SS (2015) A trial for the ages. Science 349:1275–1278.  https://doi.org/10.1126/science.349.6254.1274CrossRefGoogle Scholar
  9. Jin K, Simpkins JW, Ji X et al (2015) The critical need to promote research of aging and aging-related diseases to improve health and longevity of the elderly population. Aging Dis 6:1–5.  https://doi.org/10.14336/AD.2014.1210CrossRefGoogle Scholar
  10. Longevity for All (2018) Longevity day and longevity month. http://www.longevityforall.org/. Accessed 15 Feb 2019
  11. Longevity International (2018) Longevity industry landscape overview. Longevity International, London. https://www.longevity.international/. Accessed 15 Feb 2019Google Scholar
  12. López-Otín C, Blasco MA, Partridge L et al (2013) The hallmarks of aging. Cell 153:1194–1217.  https://doi.org/10.1016/j.cell.2013.05.039CrossRefGoogle Scholar
  13. Newman JC, Milman S, Hashmi SK et al (2016) Strategies and challenges in clinical trials targeting human aging. J Gerontol A Biol Sci Med Sci 71:1424–1434.  https://doi.org/10.1093/gerona/glw149CrossRefGoogle Scholar
  14. Olshansky SJ, Perry D, Miller RA, Butler RN (2006) In pursuit of the longevity dividend: what should we be doing to prepare for the unprecedented aging of humanity? Scientist 20(3):28–36Google Scholar
  15. Partridge B, Lucke J, Bartlett H, Hall W (2009) Ethical, social, and personal implications of extended human lifespan identified by members of the public. Rejuvenation Res 12:351–357.  https://doi.org/10.1089/rej.2009.0907CrossRefGoogle Scholar
  16. Partridge B, Lucke J, Bartlett H, Hall W (2011) Public attitudes towards human life extension by intervening in ageing. J Aging Stud 25(2):73–83.  https://doi.org/10.1016/j.jaging.2010.08.012CrossRefGoogle Scholar
  17. Rae MJ, Butler RN, Campisi J et al (2010) The demographic and biomedical case for late-life interventions in aging. Sci Transl Med 2:40cm21.  https://doi.org/10.1126/scitranslmed.3000822CrossRefGoogle Scholar
  18. Smol’kin AA, Zhigareva PA, Makarova EA et al (2018) Attitudes towards aging prevention: results of a focus-group study. Adv Gerontol 8:71–78.  https://doi.org/10.1134/S2079057018010125CrossRefGoogle Scholar
  19. Stambler I (2017a) Recognizing degenerative aging as a treatable medical condition: methodology and policy. Aging Dis 8:583–589.  https://doi.org/10.14336/AD.2017.0130CrossRefGoogle Scholar
  20. Stambler I (2017b) Longevity promotion: multidisciplinary perspectives. Longevity history, Rishon Lezion. http://www.longevityhistory.com/. Accessed 15 Feb 2019
  21. Stambler I, Jin K, Lederman S et al (2018) Aging health and R&D for healthy longevity must be included into the WHO work program. Aging Dis 9(2):331–333.  https://doi.org/10.14336/AD.2017.1120CrossRefGoogle Scholar
  22. The Lancet Diabetes and Endocrinology (2018) Opening the door to treating ageing as a disease. Lancet Diabetes Endocrinol 6(8):587.  https://doi.org/10.1016/S2213-8587(18)30214-6CrossRefGoogle Scholar
  23. Underwood M (2014) What reassurances do the community need regarding life extension? Evidence from studies of community attitudes and an analysis of film portrayals. Rejuvenation Res 17:105–115.  https://doi.org/10.1089/rej.2013.1479CrossRefGoogle Scholar
  24. Vetek (Seniority) – the Movement for Longevity and Quality of Life (2019). http://www.longevityisrael.org/. Accessed 15 Feb 2019
  25. World Health Organization (2015) Global strategy and action plan on ageing and health (GSAP) – 2016–2020. World Health Organization, Geneva. http://www.who.int/ageing/global-strategy/en/. Accessed 15 Feb 2019
  26. World Health Organization (2018) Thirteenth general programme of work, 2019–2023. World Health Organization, Geneva. https://www.who.int/about/what-we-do/gpw-thirteen-consultation/en/. Accessed 15 Feb 2019Google Scholar

Copyright information

© This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2019

Authors and Affiliations

  1. 1.Science, Technology and SocietyBar Ilan UniversityRamat GanIsrael
  2. 2.Life Extension Advocacy FoundationNew York CityUSA

Section editors and affiliations

  • Ilia Stambler
    • 1
  1. 1.Science, Technology and SocietyBar Ilan UniversityRamat GanIsrael